Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,875
Closed -$750K 38
2023
Q4
$750K Sell
6,875
-9,143
-57% -$949K 0.7% 21
2023
Q3
$1.65M Sell
16,018
-260
-2% -$28K 1.13% 17
2023
Q2
$1.88M Sell
16,278
-1,090
-6% -$124K 1.22% 14
2023
Q1
$1.85M Buy
17,368
+118
+0.7% +$12.7K 1.23% 16
2022
Q4
$1.91M Buy
+17,250
New +$1.76M 1.36% 14

Other funds holding MRK

AFS Financial Group's MRK Position: Q1 2024 in Review

AFS Financial Group sold out of Merck (MRK) in Q1 2024, closing a stake of 6,875 shares — an estimated $750K sold.

AFS Financial Group first reported a position in MRK in Q4 2022 and held it in 5 quarters. The position peaked at $1.91M in Q4 2022. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • AFS Financial Group reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • AFS Financial Group sold 6,875 Merck shares in Q1 2024, an estimated $750K.
  • AFS Financial Group first reported a position in Merck in Q4 2022 and held it in 5 quarters.
  • AFS Financial Group's Merck position peaked at $1.91M in Q4 2022.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on AFS Financial Group's 13F filing for Q1 2024, filed 3 May 2024.